Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2013

View Archived Issues

Diabetes drug may be useful in treatment of X-linked adrenoleukodystrophy

Fecal metagenome associated with glucose control in a European cohort

A novel GABA(A) receptor agonist PET ligand shows good brain uptake in non-human primates

Curie-Cancer and Sanofi collaboration targets ovarian cancer therapeutics

Celgene presents results for apremilast in psoriatic arthritis and Behcet's syndrome

Silenseed's siG12D LODER evaluated for pancreatic cancer

Diffusion Pharmaceuticals' private financing round to support phase II trial in GBM

DBV Technologies reports data from Viaskin Peanut study

Actelion Pharmaceuticals divulges novel antibacterial agents

Researchers at BIKAM Pharmaceuticals disclose new agents for ophthalmic disorders

Novel CCR4 receptor antagonists prepared by ChemoCentryx

Initiation of clinical trials for IDX-20963 on hold following FDA request

AiCuris patents novel reverse transcriptase inhibitors for HIV infection

Protalix BioTherapeutics profiles three new compounds

Researchers in The Netherlands synthesize novel products

Takeda submits BLA to the FDA for vedolizumab

3-V Biosciences completes financing round for novel fatty acid synthase inhibitor

Amarin reports results from phase I trial of AMR-102

Bionor Pharma obtains GLOBVAC grant to advance research on Vacc-HIV

FDA approves genotyping test for patients with hepatitis C virus

FDA grants breakthrough therapy designation to serelaxin for acute heart failure

Medicago produces plant-based rotavirus vaccine candidate

FDA accepts for review sNDA to expand Xeljanz label

FDA approves Vibativ for hospital-acquired and ventilator-associated bacterial pneumonia

Boehringer Ingelheim seeks EMA approval of Pradaxa for DVT and PE indications

Xtandi approved in Europe for advanced prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...